首页> 外文期刊>Frontiers in Nutrition >Effects of Probiotic Supplementation on TGF-β1, TGF-β2, and IgA Levels in the Milk of Japanese Women: An Open-label Pilot Study
【24h】

Effects of Probiotic Supplementation on TGF-β1, TGF-β2, and IgA Levels in the Milk of Japanese Women: An Open-label Pilot Study

机译:补充益生菌对日本女性牛奶中TGF-β1,TGF-β2和IgA的影响:一项开放性试验研究

获取原文
           

摘要

Abstract Background: Dietary probiotics supplementation in lactating mothers may help prevent allergic disease in infants. However, owing to a lack of consistency in nutritional and safety outcomes associated with probiotics, this topic remains controversial. Methods: In this open-label pilot trial conducted between April 2013 and December 2013, we evaluated the safety of probiotic supplementation with 5 × 109 CFU of Lactobacillus casei LC5, 5 × 109 CFU of Bifidobacterium longum BG7, and 2 × 108 CFU of Bacillus coagulans SANK70258 in lactating women who exhibited allergies for 2 months (1-3 months postpartum); we also evaluated the effects of probiotic supplementation on transforming growth factor-β (TGF-β) and immunoglobulin A (IgA) levels in human milk. Participants self-selected to join the probiotic (n = 41; age [median (interquartile range [IQR]), y] 33 [27-39], body mass index [BMI] [median (IQR), kg/m2] 21.8 [19.5-22.8]) or no supplementation control group (n = 19; age [median (IQR), y] 33 [23-43], BMI [median (IQR), kg/m2) 19.6 [18.4-22.1]). Probiotics (three tablets) received were taken as daily supplements. Milk samples were collected at one, 2, and 3 months postpartum, and TGF-β1, TGF-β2, and IgA levels were measured. Results: No adverse effects were observed in the probiotic group, according to the self-recorded diary during the study period. Milk IgA decreased with increasing postpartum months in both groups. In contrast, TGF-β1 and β2 were not affected by lactation periods, and showed different patterns over time between the two groups. TGF-β1, TGF-β1, and IgA levels were significantly correlated at baseline (respectively p 0.05). However, the correlation between TGF-β1 and IgA became non-significant by the end of the intervention (p = 0.063). Conclusion: Altogether, probiotic supplementation was tolerated with respect to no dropout and 91.5% adherence. Although probiotic supplementation might affect human milk TGF-β levels, a positive effect of probiotic supplementation was not entirely supported. Future placebo-controlled studies are needed to further support the efficacy and safety of probiotic supplementation.
机译:摘要背景:哺乳期母亲饮食中添加益生菌可能有助于预防婴儿过敏性疾病。但是,由于与益生菌有关的营养和安全性结果缺乏一致性,因此该话题仍然存在争议。方法:在2013年4月至2013年12月进行的这项开放标签的先导试验中,我们评估了添加5×109 CFU干酪乳杆菌LC5、5×109 CFU长双歧杆菌BG7和2×108 CFU益生菌的安全性。哺乳期妇女过敏2个月(产后1-3个月)的凝结物SANK70258;我们还评估了补充益生菌对母乳中转化生长因子-β(TGF-β)和免疫球蛋白A(IgA)水平的影响。自行选择参加益生菌的参与者(n = 41;年龄[中位数(四分位间距[IQR]),y] 33 [27-39],体重指数[BMI] [中位数(IQR),kg / m2] 21.8 [19.5-22.8])或无补充对照组(n = 19;年龄[中位数(IQR),y] 33 [23-43],BMI [中位数(IQR),kg / m2)19.6 [18.4-22.1]) 。服用的益生菌(三片)作为每日补充。在产后1、2和3个月收集牛奶样品,并测量TGF-β1,TGF-β2和IgA水平。结果:根据研究期间的自录日记,益生菌组未见不良反应。两组的产后月数随着牛奶IgA的降低而降低。相反,TGF-β1和β2不受泌乳期的影响,两组之间随时间的变化呈现出不同的模式。在基线时,TGF-β1,TGF-β1和IgA水平显着相关(分别为p <0.05)。然而,到干预结束时,TGF-β1和IgA之间的相关性变得不显着(p = 0.063)。结论:总的来说,益生菌补充剂可耐受无脱落和91.5%的依从性。尽管补充益生菌可能会影响人乳中TGF-β的水平,但仍未完全支持补充益生菌的积极作用。需要进一步的安慰剂对照研究来进一步支持益生菌补充剂的功效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号